You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 15, 2025

Details for New Drug Application (NDA): 018321

✉ Email this page to a colleague

NDA 018321 describes TECHNESCAN, which is a drug marketed by Curium and Draximage and is included in five NDAs. It is available from one supplier. Additional details are available on the TECHNESCAN profile page.

The generic ingredient in TECHNESCAN is technetium tc-99m pyrophosphate kit. There are four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the technetium tc-99m pyrophosphate kit profile page.

Summary for 018321

Tradename:	TECHNESCAN
Applicant:	Curium
Ingredient:	technetium tc-99m oxidronate kit
Patents:	0

Suppliers and Packaging for NDA: 018321

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
TECHNESCAN	technetium tc-99m oxidronate kit	INJECTABLE;INJECTION	018321	NDA	Curium US LLC	69945-091	69945-091-20	5 VIAL in 1 CELLO PACK (69945-091-20) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL
TECHNESCAN	technetium tc-99m oxidronate kit	INJECTABLE;INJECTION	018321	NDA	Curium US LLC	69945-091	69945-091-40	30 VIAL in 1 CARTON (69945-091-40) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	INJECTABLE;INJECTION			Strength	N/A
Approval Date:	Approved Prior to Jan 1, 1982	TE:		RLD:	Yes

Expired US Patents for NDA 018321

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Curium	TECHNESCAN	technetium tc-99m oxidronate kit	INJECTABLE;INJECTION	018321-001	Approved Prior to Jan 1, 1982	4,497,744	⤷ Get Started Free
Curium	TECHNESCAN	technetium tc-99m oxidronate kit	INJECTABLE;INJECTION	018321-001	Approved Prior to Jan 1, 1982	4,432,963	⤷ Get Started Free
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.